top of page
%20(11_087%20x%207%20in).jpg)
NEW BOOK
LATEST NEWS
Capricor's Shares Drop After FDA Rejects Deramiocel Cell Therapy for Heart Disease in DMD
Capricor Therapeutics faced a significant setback on July 11, 2025, when the FDA rejected its cell therapy, Deramiocel , for treating...
2 days ago
FDA Rejects Ultragenyx's Gene Therapy for Rare Disease - Sanfilippo Syndrome
The FDA has declined to approve Ultragenyx Pharmaceutical's gene therapy, UX111, for treating Sanfilippo syndrome type A, a rare genetic...
3 days ago
Biogen's Salanersen Shows Promise for SMA Patients Post-Gene Therapy
Biogen’s experimental drug, Salanersen, is showing promising potential for treating children with spinal muscular atrophy (SMA), even...
Jul 1
GENE TECH TIMES
The Future Has Arrived
Magnets: The New Way to Control the Brain?
Imagine switching brain circuits on and off using only magnetic fields. Researchers have just developed a cutting-edge gene therapy that...
Oct 15, 2024
New Gene Therapy Breakthrough Paves Way for Better Treatment of Brain Disorders
In a project funded by the National Institute of Mental Health (NIMH) and the National Institute of Neurological Disorders and Stroke...
Aug 20, 2024
FDA Expands Approval of ELEVIDYS: A Breakthrough Gene Therapy for Duchenne Muscular Dystrophy
On June 20th, 2024, the FDA expanded its approval of ELEVIDYS , an innovative AAV-based gene therapy developed by Sarepta Therapeutics ,...
Jun 20, 2024
bottom of page